Clinical Trial Update: Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tacrolimus with Mycophenolate mofetil versus tacrolimus with sirolimus for living donor kidney transplant patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of Miami | Conditions: Living Donor Kidney Transplants Patients | Phase 4 | Status: WITHDRAWN